Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Oral Suspension in Pediatric Epilepsy (Study 311)
NCT02849626Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2016
- Primary completion
- Feb 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of perampanel in focal onset seizure, generalized tonic-clonic seizure (GTCS), sponsored by Eisai Co., Ltd.. Started Nov 2016; status: completed.
02
Drugs
perampanel
03
Conditions
focal onset seizuregeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on NCT02849626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849626.